CopyRight®pharmtec.cn 2019 All Right Reserved Jiangsu ICP No.10067022 Powered by：www.300.cn nanjing.300.cn
Project Recommendation
产品名称
ZL-04
Product description
Therapeutic area
Cardiovascular
Registration classification
2 class
Dosage form
Sublingual tablet
R & D stage
Preclinical
Treatment of heart failure and arrhythmia. It is a modified substitute for digoxin and has the characteristics of low dose, quick action and little side effect.